A Clínic-IDIBAPS-led study describes new mechanisms linking the locus coeruleus to deep sleep and reveals differences according to sex and cerebral...
The introduction of blood biomarkers for Alzheimer’s disease is revolutionizing the biological diagnosis of this disease, enabling faster diagnosis...
The treatments available for Alzheimer’s disease are most effective in the early stages, when it is still asymptomatic. That is why an early diagno...
Numerous scientific studies have identified preventable potential risk factors for the development of dementia. Fourteen of these factors and their...
HUB Alzheimer Barcelona is a pioneering collaborative initiative rooted in a commitment to transform the future of research and provide support for...
These findings offer a solid basis for designing clinical trials of therapies aimed at modifying the development of these neurodegenerative disease...
Researchers at the Clínic-IDIBAPS led a study published in the Alzheimer’s & Dementia journal on the relationship between the integrity of the locu...
The centre becomes the first in Spain to use blood biomarker p-tau217, which offers a more accurate and less invasive diagnosis and marks a paradig...
With the expansion of the Day Hospital for Neurodegenerative Diseases at the Clínic Barcelona Hospital, it will be possible to receive over 15,000...
Frontotemporal dementia (FTD) and Alzheimer's disease are two different forms of dementia, which can often be confused due to sharing some of the s...
